Negatively charged porous medium for removing protein aggregates
US-2016051943-A1 · Feb 25, 2016 · US
US9951101B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9951101-B2 |
| Application number | US-201415033940-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 6, 2014 |
| Priority date | Dec 12, 2013 |
| Publication date | Apr 24, 2018 |
| Grant date | Apr 24, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel compositions for removing impurities such as, protein aggregates, from a sample containing a protein of interest, e.g., an antibody. Such compositions can be used prior to the virus filtration step during protein purification, to remove aggregates and protect the virus filter from fouling, therefore improving virus filter capacity. A porous solid support including a co-polymer having at least two monomers, wherein at least one of the monomers comprises acrylamide and at least a second monomer comprises a hydrophobic binding group, where the solid support selectively binds protein aggregates, thereby to separate the monomeric protein of interest from the protein aggregates. The method can be performed under neutral to high pH and high conductivity conditions.
Opening claim text (preview).
What is claimed is: 1. A method of separating a monomeric protein of interest from protein aggregates in a sample by porous membrane filtration, the method comprising contacting the sample with a porous membrane comprising a cross-linked coating comprising a co-polymer of benzyl acrylamide, acrylamide and N,N′-methylenebisacrylamide, wherein the membrane selectively binds protein aggregates, thereby separating the monomeric protein of interest from the protein aggregates. 2. The method of claim 1 wherein the method is performed at neutral to higher pH of 6 or greater. 3. The method of claim 1 wherein the method is performed in a solution of moderate to high conductivity of 5 mS/cm or greater. 4. The method of claim 1 , wherein the protein aggregates are selected from the group consisting of dimers, trimers, and tetramers. 5. The method of claim 1 , wherein the aggregates are pentamers and higher. 6. The method of claim 1 , wherein the monomeric protein of interest is an antibody. 7. The method of claim 6 , wherein the antibody is a monoclonal antibody. 8. The method of claim 1 , wherein the monomeric protein of interest is a recombinant protein. 9. The method of claim 1 , wherein the monomeric protein of interest is a polyclonal antibody. 10. The method of claim 1 , wherein the monomeric protein of interest is further subjected to filtration through a virus-retentive filter.
consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds · CPC title
by filtration, ultrafiltration or reverse osmosis · CPC title
Amides {, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide} · CPC title
Polar phases · CPC title
Aspects related to sorbents specially adapted for preparative, analytical or investigative chromatography · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.